undefined undefined
NaN.000
NaN.00%
Although U.S. stocks closed lower on Thursday, there were a few notable insider...
04-26 19:36
瑞银:维持Biohaven(BHVN.US)评级,由买入调整至买入评级, 目标价由59.00美元调整至60.00美元。
04-23 23:41
Biopharmaceutical company Biohaven (NYSE:BHVN) priced its underwritten public offering of ~5.61M shares at a price to the public of $41.00 per share. Underwriters have a 30-day option to purchase u...
04-18 18:12
Biohaven Ltd. (NYSE:BHVN), a biopharmaceutical company focused on the discovery, development and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience and oncology,
04-18 04:15
Shares of Biohaven (NYSE:BHVN) slid 15% in early afternoon trading Monday amid presentations for its various drug candidates at two industry meetings. Early Monday, Biohaven said that the inventor of ...
04-16 01:54
The latest update is out from Biohaven Ltd. (BHVN). David Spiegel, the mind beh...
04-15 19:12
Cantor Fitzgerald analyst Charles Duncan reiterates Biohaven (NYSE:BHVN) with a Overweight.
04-11 01:28
加拿大皇家银行:重申Biohaven(BHVN.US)评级,由优于大市调整至优于大市评级, 目标价61.00美元。
04-09 21:21
Latest findings on Altimmune's pemvidutide on body composition: lean mass preservation, significant weight loss from adipose tissue, and results in obesity and Metabolic dysfunction-associated steatohepatitis trials.
03-27 21:31